Lipid body function in eicosanoid synthesis: An update

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 85, Issue 5, 2011, Pages 205-213

  Bozza, Patricia T ^a   Bakker Abreu, Ilka ^b   Navarro Xavier, Roberta A ^a   Bandeira Melo, Christianne ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADIPOPHILIN; ANTIALLERGIC AGENT; ANTILIPEMIC AGENT; ARACHIDONATE 5 LIPOXYGENASE; CAVEOLIN 1; CYTOSOLIC PHOSPHOLIPASE A2; FAT DROPLET; ICOSANOID; NONSTEROID ANTIINFLAMMATORY AGENT; PERILIPIN;

ARTICLE; BIOGENESIS; CELL ACTIVATION; CELL ASSAY; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL SPECIFICITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME REPRESSION; HUMAN; ICOSANOID METABOLISM; INFLAMMATION; INTRACELLULAR SIGNALING; LEUKOCYTE ACTIVATION; LIPID MEMBRANE; LIPID STORAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEIN INTERACTION;

ANIMALS; EICOSANOIDS; HUMANS; INFECTION; INFLAMMATION; LIPID METABOLISM; NEOPLASMS; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS;

EID: 80053578505     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2011.04.020     Document Type: Article

References (94)

1. Yaqoob P. Fatty acids as gatekeepers of immune cell regulation. Trends Immunol. 2003, 24:639-645.
2. Wymann M.P., Schneiter R. Lipid signalling in disease. Nat. Rev. Mol. Cell Biol. 2008, 9:162-176.
3. Peters-Golden M., Brock T.G. Intracellular compartmentalization of leukotriene synthesis: unexpected nuclear secrets. FEBS Lett. 2001, 487:323-326.
4. Mandal A.K., Skoch J., Bacskai B.J., Hyman B.T., Christmas P., Miller D., Yamin T.T., Xu S., Wisniewski D., Evans J.F., Soberman R.J. The membrane organization of leukotriene synthesis. Proc. Natl. Acad. Sci. USA 2004, 101:6587-6592.
5. Bandeira-Melo C., Bozza P.T., Weller P.F. The cellular biology of eosinophil eicosanoid formation and function. J. Allergy Clin. Immunol. 2002, 109:393-400.
6. Bozza P.T., Magalhaes K.G., Weller P.F. Leukocyte lipid bodies - Biogenesis and functions in inflammation. Biochim Biophys Acta 2009, 1791:540-551.
7. Tauchi-Sato K., Ozeki S., Houjou T., Taguchi R., Fujimoto T. The surface of lipid droplets is a phospholipid monolayer with a unique fatty acid composition. J. Biol. Chem. 2002, 277:44507-44512.
8. Martin S., Parton R.G. Lipid droplets: a unified view of a dynamic organelle. Nat. Rev. Mol. Cell Biol. 2006, 7:373-378.
9. Goodman J.M. Demonstrated and inferred metabolism associated with cytosolic lipid droplets. J. Lipid Res. 2009, 50:2148-2156.
10. Murphy S., Martin S., Parton R.G. Lipid droplet-organelle interactions; sharing the fats. Biochim. Biophys. Acta. 2009, 1791:441-447.
11. Bozza P.T., Yu W., Penrose J.F., Morgan E.S., Dvorak A.M., Weller P.F. Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation. J. Exp. Med. 1997, 186:909-920.
12. 2 synthesis in colon cancer cells. Cancer Res. 2008, 68:1732-1740.
13. Robenek M.J., Severs N.J., Schlattmann K., Plenz G., Zimmer K.P., Troyer D., Robenek H. Lipids partition caveolin-1 from ER membranes into lipid droplets: updating the model of lipid droplet biogenesis. FASEB J. 2004, 18:866-868.
14. Wan H.C., Melo R.C., Jin Z., Dvorak A.M., Weller P.F. Roles and origins of leukocyte lipid bodies: proteomic and ultrastructural studies. FASEB J. 2007, 21:167-178.
15. Robenek H., Robenek M.J., Troyer D. PAT family proteins pervade lipid droplet cores. J Lipid Res. 2005, 46:1331-1338.
16. Heid H.W., Moll R., Schwetlick I., Rackwitz H.R., Keenan T.W. Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res. 1998, 294:309-321.
17. Brasaemle D.L., Barber T., Wolins N.E., Serrero G., Blanchette-Mackie E.J., Londos C. Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein. J. Lipid Res. 1997, 38:2249-2263.
18. Bozza P.T., Viola J.P. Lipid droplets in inflammation and cancer. Prostaglandins Leukot. Essent. Fatty Acids 2010, 82:243-250.
19. Dvorak A.M., Dvorak H.F., Peters S.P., Shulman E.S., MacGlashan D.W., Pyne K., Harvey V.S., Galli S.J., Lichtenstein L.M. Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J. Immunol. 1983, 131:2965-2976.
20. Weller P.F., Ackerman S.J., Nicholson-Weller A., Dvorak A.M. Cytoplasmic lipid bodies of human neutrophilic leukocytes. Am. J. Pathol. 1989, 135:947-959.
21. Weller P.F., Monahan-Earley R.A., Dvorak H.F., Dvorak A.M. Cytoplasmic lipid bodies of human eosinophils. subcellular isolation and analysis of arachidonate incorporation. Am. J. Pathol. 1991, 138:141-148.
22. 3H] arachidonic acid incorporeted by mast cells, macrophages and other cell types. Prostaglandins, Leukotrienes, and Lipoxins 1985, Plenum Publishing, New York, pp. 221-239. J.M. Bailey (Ed.).
23. Plotkowski M.C., Brandao B.A., de Assis M.C., Feliciano L.F., Raymond B., Freitas C., Saliba A.M., Zahm J.M., Touqui L., Bozza P.T. Lipid body mobilization in the ExoU-induced release of inflammatory mediators by airway epithelial cells. Microb. Pathog. 2008, 45:30-37.
24. Triggiani M., Oriente A., Seeds M.C., Bass D.A., Marone G., Chilton F.H. Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool. J. Exp. Med. 1995, 182:1181-1190.
25. 2 at cytoplasmic arachidonate-rich lipid bodies. Am. J. Pathol. 1998, 152:759-769.
26. Oddi S., Fezza F., Pasquariello N., De Simone C., Rapino C., Dainese E., Finazzi-Agro A., Maccarrone M. Evidence for the intracellular accumulation of anandamide in adiposomes. Cell Mol. Life Sci. 2008, 65:840-850.
27. 2 superfamily and its group numbering system. Biochim. Biophys. Acta 2006, 1761:1246-1259.
28. Moreira L.S., Piva B., Gentile L.B., Mesquita-Santos F.P., D'Avila H., Maya-Monteiro C.M., Bozza P.T., Bandeira-Melo C., Diaz B.L. Cytosolic phospholipase A2-driven PGE2 synthesis within unsaturated fatty acids-induced lipid bodies of epithelial cells. Biochim. Biophys. Acta-Mol. Cell Biol. Lipids 2009, 1791:156-165.
29. Wooten R.E., Willingham M.C., Daniel L.W., Leslie C.C., Rogers L.C., Sergeant S., O'Flaherty J.T. Novel translocation responses of cytosolic phospholipase A(2)alpha fluorescent proteins. Biochim. Biophys. Acta 2008, 1783:1544-1550.
30. Bozza P.T., Weller P.F. Arachidonyl trifluoromethyl ketone induces lipid body formation in leukocytes. Prostaglandins Leukot. Essent. Fatty Acids 2001, 64:227-230.
31. Sato H., Frank D.W., Hillard C.J., Feix J.B., Pankhaniya R.R., Moriyama K., Finck-Barbancon V., Buchaklian A., Lei M., Long R.M., Wiener-Kronish J., Sawa T. The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J. 2003, 22:2959-2969.
32. Phillips R.M., Six D.A., Dennis E.A., Ghosh P. In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors. J. Biol. Chem. 2003, 278:41326-41332.
33. Johnson M.M., Vaughn B., Triggiani M., Swan D.D., Fonteh A.N., Chilton F.H. Role of arachidonyl triglycerides within lipid bodies in eicosanoid formation by human polymorphonuclear cells. Am. J. Respir. Cell Mol. Biol. 1999, 21:253-258.
34. Liu P., Ying Y., Zhao Y., Mundy D.I., Zhu M., Anderson R.G. Chinese hamster ovary K2 cell lipid droplets appear to be metabolic organelles involved in membrane traffic. J. Biol. Chem. 2004, 279:3787-3792.
35. Brasaemle D.L., Dolios G., Shapiro L., Wang R. Proteomic analysis of proteins associated with lipid droplets of basal and lipolytically stimulated 3T3-L1 adipocytes. J. Biol. Chem. 2004, 279:46835-46842.
36. Dvorak A.M., Morgan E., Schleimer R.P., Ryeom S.W., Lichtenstein L.M., Weller P.F. Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. J. Histochem. Cytochem. 1992, 40:759-769.
37. Dvorak A.M., Weller P.F., Harvey V.S., Morgan E.S., Dvorak H.F. Ultrastructural localization of prostaglandin endoperoxide synthase (cyclooxygenase) to isolated, purified fractions of guinea pig peritoneal macrophage and line 10 hepatocarcinoma cell lipid bodies. Int. Arch. Allergy Immunol. 1993, 101:136-142.
38. Bozza P.T., Yu W., Cassara J., Weller P.F. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. J. Leukoc. Biol. 1998, 64:563-569.
39. Pacheco P., Bozza F.A., Gomes R.N., Bozza M., Weller P.F., Castro-Faria-Neto H.C., Bozza P.T. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. J. Immunol. 2002, 169:6498-6506.
40. D'Avila H., Melo R.C.N., Parreira G.G., Werneck-Barroso E., Castro-Faria-Neto H.C., Bozza P.T. Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J. Immunol. 2006, 176:3087-3097.
41. 4 synthesis within eosinophils. Am. J. Respir. Cell Mol. Biol. 2005, 33:254-261.
42. Maya-Monteiro C.M., Almeida P.E., D'Avila H., Martins A.S., Rezende A.P., Castro-Faria-Neto H., Bozza P.T. Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism. J. Biol. Chem. 2008, 283:2203-2210.
43. Bresell A., Weinander R., Lundqvist G., Raza H., Shimoji M., Sun T.H., Balk L., Wiklund R., Eriksson J., Jansson C., Persson B., Jakobsson P.J., Morgenstern R. Bioinformatic and enzymatic characterization of the MAPEG superfamily. FEBS J. 2005, 272:1688-1703.
44. Silva A.R., Pacheco P., Vieira-de-Abreu A., Maya-Monteiro C.M., D'Alegria B., Magalhaes K.G., de Assis E.F., Bandeira-Melo C., Castro-Faria-Neto H.C., Bozza P.T. Lipid Bodies in oxidized LDL-induced foam cells are leukotriene-synthesizing organelles: A MCP-1/CCL2 regulated phenomenon. Biochim. Biophys. Acta 2009, 1791:1066-1075.
45. Araujo-Santos T., Prates D.B., Andrade B.B., Nascimento D.O., Clarencio J., Entringer P.F., Carneiro A.B., Silva-Neto M.A., Miranda J.C., Brodskyn C.I., Barral A., Bozza P.T., Borges V.M. Lutzomyia longipalpis saliva triggers lipid body formation and prostaglandin E production in murine macrophages. PLoS Negl. Trop. Dis. 2010, 4:e873.
46. Smith W.L., DeWitt D.L., Garavito R.M. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 2000, 69:145-182.
47. Bandeira-Melo C., Phoofolo M., Weller P.F. Extranuclear lipid bodies, elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils. J. Biol. Chem. 2001, 276:22779-22787.
48. Peters-Golden M., McNish R.W. Redistribution of 5-lipoxygenase and cytosolic phospholipase A2 to the nuclear fraction upon macrophage activation. Biochem. Biophys. Res. Commun. 1993, 196:147-153.
49. Pacheco P., Vieira-de-Abreu A., Gomes R.N., Barbosa-Lima G., Wermelinger L.B., Maya-Monteiro C.M., Silva A.R., Bozza M.T., Castro-Faria-Neto H.C., Bandeira-Melo C., Bozza P.T. Monocyte chemoattractant protein-1/CC chemokine ligand 2 controls microtubule-driven biogenesis and leukotriene B4-synthesizing function of macrophage lipid bodies elicited by innate immune response. J. Immunol. 2007, 179:8500-8508.
50. Woods J.W., Evans J.F., Ethier D., Scott S., Vickers P.J., Hearn L., Heibein J.A., Charleson S. Singer, II, 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 1993, 178:1935-1946.
51. Woods J.W., Coffey M.J., Brock T.G., Singer M. Peters-Golden, 5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation. J. Clin. Invest. 1995, 95:2035-2046.
52. Brock T.G., Maydanski E., McNish R.W., Peters-Golden M. Co-localization of leukotriene a4 hydrolase with 5-lipoxygenase in nuclei of alveolar macrophages and rat basophilic leukemia cells but not neutrophils. J. Biol. Chem. 2001, 276:35071-35077.
53. 2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis. J. Biol. Chem. 2006, 281:6691-6698. Group.
54. 4 synthesis accompanies adherence-dependent nuclear import of 5-lipoxygenase in human blood eosinophils. J. Immunol. 1999, 162:1669-1676.
55. Seachord C.L., VandeVoort C.A., Duffy D.M. Adipose differentiation-related protein: a gonadotropin- and prostaglandin-regulated protein in primate periovulatory follicles. Biol. Reprod. 2005, 72:1305-1314.
56. Arend A., Masso R., Masso M., Selstam G. Electron microscope immunocytochemical localization of cyclooxygenase-1 and -2 in pseudopregnant rat corpus luteum during luteolysis. Prostaglandins Other Lipid Mediat. 2004, 74:1-10.
57. Meadows J.W., Eis A.L., Brockman D.E., Myatt L. Expression and localization of prostaglandin E synthase isoforms in human fetal membranes in term and preterm labor. J. Clin. Endocrinol. Metab. 2003, 88:433-439.
58. Meadows J.W., Pitzer B., Brockman D.E., Myatt L. Expression and localization of adipophilin and perilipin in human fetal membranes: association with lipid bodies and enzymes involved in prostaglandin synthesis. J. Clin. Endocrinol. Metab. 2005, 90:2344-2350.
59. Dvorak A.M., Morgan E.S., Tzizik D.M., Weller P.F. Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmic lipid bodies in human eosinophils and 3T3 fibroblasts. Int. Arch Allergy Immunol. 1994, 105:245-250.
60. Scarfo L.M., Weller P.F., Farber H.W. Induction of endothelial cell cytoplasmic lipid bodies during hypoxia. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H294-301.
61. Blaner W.S., O'Byrne S.M., Wongsiriroj N., Kluwe J., D'Ambrosio D.M., Jiang H., Schwabe R.F., Hillman E.M., Piantedosi R., Libien J. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim. Biophys. Acta 2009, 1791:467-473.
62. Friedman S.L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev. 2008, 88:125-172.
63. Borojevic R., Guaragna R.M., Margis R., Dutra H.S. In vitro induction of the fat-storing phenotype in a liver connective tissue cell line-GRX. In Vitro Cell Dev. Biol. 1990, 26:361-368.
64. Guaragna R.M., Trugo L., Borojevic R. Neutral lipid synthesis and accumulation during in vitro induction of the lipocyte phenotype in hepatic connective tissue cells. Biochim. Biophys. Acta 1991, 1085:29-34.
65. Paiva L.A., Maya-Monteiro C.M., Bandeira-Melo C., Silva P.M., El-Cheikh M.C., Teodoro A.J., Borojevic R., Perez S.A., Bozza P.T. Interplay of cysteinyl leukotrienes and TGF-beta in the activation of hepatic stellate cells from Schistosoma mansoni granulomas. Biochim. Biophys. Acta 2010, 1801:1341-1348.
66. D'Avila H., Melo R.C., Parreira G.G., Werneck-Barroso E., Castro-Faria-Neto H.C., Bozza P.T. Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J. Immunol. 2006, 176:3087-3097.
67. Sorgi C.A., Secatto A., Fontanari C., Turato W.M., Belanger C., de Medeiros A.I., Kashima S., Marleau S., Covas D.T., Bozza P.T., Faccioli L.H. Histoplasma capsulatum cell wall {beta}-glucan induces lipid body formation through CD18, TLR2, and dectin-1 receptors: correlation with leukotriene B4 generation and role in HIV-1 infection. J. Immunol. 2009, 182:4025-4035.
68. de Assis E.F., Silva A.R., Caiado L.F., Marathe G.K., Zimmerman G.A., Prescott S.M., McIntyre T.M., Bozza P.T., de Castro-Faria-Neto H.C. Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytes. J. Immunol. 2003, 171:2090-2098.
69. Weibel G.L., Joshi M.R., Wei C., Bates S.R., Blair I.A., Rothblat G.H. 15(S)-Lipoxygenase-1 associates with neutral lipid droplets in macrophage foam cells: evidence of lipid droplet metabolism. J. Lipid Res. 2009, 50:2371-2376.
70. Tedla N., Bandeira-Melo C., Tassinari P., Sloane D.E., Samplaski M., Cosman D., Borges L., Weller P.F., Arm J.P. Activation of human eosinophils through leukocyte immunoglobulin-like receptor 7. Proc. Natl Acad. Sci. USA 2003, 100:1174-1179.
71. Mesquita-Santos F.P., Bakker-Abreu I., Luna-Gomes T., Bozza P.T., Diaz B.L., Bandeira-Melo C. Co-operative signalling through DP(1) and DP(2) prostanoid receptors is required to enhance leukotriene C(4) synthesis induced by prostaglandin D(2) in eosinophils. Br. J. Pharmacol. 2011, 162:1674-1685.
72. 4 Synthesis by Eosinophils during Allergic Inflammation: Synergistic In Vivo Role of Endogenous Eotaxin. J. Immunol. 2006, 176:1326-1330.
73. 4-Synthesizing Lipid Bodies. Am. J. Respir. Cell Mol. Biol. 2011, 44:509-516.
74. 4 and structurally related conjugates. Vitam. Horm. 2002, 64:153-184.
75. 4 by the multidrug resistance protein ABCC4 (MRP4). J. Pharmacol. Exp. Ther. 2008, 324:86-94.
76. Reid G., Wielinga P., Zelcer N., van der Heijden I., Kuil A., de Haas M., Wijnholds J., Borst P. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc. Natl. Acad. Sci. USA 2003, 100:9244-9249.
77. 2 transport by multidrug resistance protein 4 deficiency alters cAMP-mediated signaling and nociceptive response. Mol. Pharmacol. 2008, 73:243-251.
78. Nishio T., Adachi H., Nakagomi R., Tokui T., Sato E., Tanemoto M., Fujiwara K., Okabe M., Onogawa T., Suzuki T., Nakai D., Shiiba K., Suzuki M., Ohtani H., Kondo Y., Unno M., Ito S., Iinuma K., Nunoki K., Matsuno S., Abe T. Molecular identification of a rat novel organic anion transporter moat1, which transports prostaglandin D(2), leukotriene C(4), and taurocholate. Biochem. Biophys. Res. Commun. 2000, 275:831-838.
79. Kerkhoff C., Klempt M., Kaever V., Sorg C. The two calcium-binding proteins, S100A8 and S100A9, are involved in the metabolism of arachidonic acid in human neutrophils. J. Biol. Chem. 1999, 274:32672-32679.
80. Roulin K., Hagens G., Hotz R., Saurat J.H., Veerkamp J.H., Siegenthaler G. The fatty acid-binding heterocomplex FA-p34 formed by S100A8 and S100A9 is the major fatty acid carrier in neutrophils and translocates from the cytosol to the membrane upon stimulation. Exp. Cell Res. 1999, 247:410-421.
81. van Manen H.J., Kraan Y.M., Roos D., Otto C. Single-cell Raman and fluorescence microscopy reveal the association of lipid bodies with phagosomes in leukocytes. Proc. Natl Acad. Sci. USA 2005, 102:10159-10164.
82. Berthier S., Paclet M.H., Lerouge S., Roux F., Vergnaud S., Coleman A.W., Morel F. Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRP8/MRP14 regulation. J. Biol. Chem. 2003, 278:25499-25508.
83. Weller P.F., Ryeom S.W., Picard S.T., Ackerman S.J., Dvorak A.M. Cytoplasmic lipid bodies of neutrophils: formation induced by cis-unsaturated fatty acids and mediated by protein kinase C. J. Cell Biol. 1991, 113:137-146.
84. Bozza P.T., Payne J.L., Goulet J.L., Weller P.F. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. J. Exp. Med. 1996, 183:1515-1525.
85. Bozza P.T., Payne J.L., Morham S.G., Langenbach R., Smithies O., Weller P.F. Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin. Proc. Natl. Acad. Sci. USA 1996, 93:11091-11096.
86. Weller P.F., Bozza P.T., Yu W., Dvorak A.M. Cytoplasmic lipid bodies in eosinophils: central roles in eicosanoid generation. Int. Arch. Allergy Immunol. 1999, 118:450-452.
87. Bartemes K.R., McKinney S., Gleich G.J., Kita H. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. J. Immunol. 1999, 162:2982-2989.
88. Melo R.C.N., D'Avila H., Fabrino D.L., Almeida P.E., Bozza P.T. Macrophage lipid body induction by Chagas disease in vivo: putative intracellular domains for eicosanoid formation during infection. Tissue Cell 2003, 35:59-67.
89. Silva A.R., de Assis E.F., Caiado L.F., Marathe G.K., Bozza M.T., McIntyre T.M., Zimmerman G.A., Prescott S.M., Bozza P.T., Castro-Faria-Neto H.C. Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. J. Immunol. 2002, 168:4112-4120.
90. Bozza P.T., Pacheco P., Yu W., Weller P.F. NS-398: cyclooxygenase-2 independent inhibition of leukocyte priming for lipid body formation and enhanced leukotriene generation. Prostaglandins Leukot. Essent. Fatty Acids 2002, 67:237-244.
91. Vieira-de-Abreu A., Amendoeira F.C., Gomes G.S., Zanon C., Chedier L.M., Figueiredo M.R., Kaplan M.A., Frutuoso V.S., Castro-Faria-Neto H.C., Weller P.F., Bandeira-Melo C., Bozza P.T. Anti-allergic properties of the bromeliaceae Nidularium procerum: inhibition of eosinophil activation and influx. Int. Immunopharmacol. 2005, 5:1966-1974.
92. D'Avila H., Roque N.R., Cardoso R.M., Castro-Faria-Neto H.C., Melo R.C.N., Bozza P.T. Neutrophils recruited to the site of Mycobacterium bovis BCG infection undergo apoptosis and modulate lipid body biogenesis and prostaglandin E production by macrophages. Cell Microbiol. 2008, 10:2589-2604.
93. Almeida P.E., Silva A.R., Maya-Monteiro C.M., Torocsik D., Avila H.D., Dezso B., Magalhaes K.G., Castro-Faria-Neto H.C., Nagy L., Bozza P.T. Mycobacterium bovis bacillus calmette-guerin infection induces TLR2-dependent peroxisome proliferator-activated receptor {gamma} Expression and activation: functions in inflammation, lipid metabolism, and pathogenesis. J. Immunol. 2009, 183:1337-1345.
94. Bezerra-Santos C.R., Vieira-de-Abreu A., Barbosa-Filho J.M., Bandeira-Melo C., Piuvezam M.R., Bozza P.T. Anti-allergic properties of Cissampelos sympodialis and its isolated alkaloid warifteine. Int. Immunopharmacol. 2006, 6:1152-1160.